Results 181 to 190 of about 54,698 (306)
Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
British Journal of Clinical Pharmacology, EarlyView.Aims
Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.Gianluca Gazzaniga, Stefano Agliardi, Riccardo Giossi, Alice Schianchi, Alessandra Romandini, Thomas Virdis, Silvia Nerini Molteni, Maria Luisa De Angelis, Stefania Paccagnini, Cecilia Gechtman, Alice Proto, Marco Fossati, Silvia Oliveri, Giulia Angela Pattarino, Elena Altieri, Agnese Graziosi, Arianna Pani, Romano Danesi, Stefano Martinelli, Costantino De Giacomo, Francesco Scaglione +20 morewiley +1 more sourceIncreasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland
British Journal of Clinical Pharmacology, EarlyView.Background
Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler +7 morewiley +1 more sourceNeurofilament light chain as in vitro and clinical biomarker of vincristine‐induced peripheral neuropathy
British Journal of Clinical Pharmacology, EarlyView.Aims
Vincristine‐induced peripheral neuropathy (VIPN) is a common side effect in children and adolescents treated with vincristine. Assessing VIPN, especially in young children, is challenging due to a lack of sensitive tools. This limits our understanding of the nature and risk factors of VIPN. This study aimed to investigate neurofilament light chain Peter Erik Lotko Pontoppidan, Christian Bach Vase, Christina Mortensen, Liv Andres‐Jensen, Dorte Aalund Olsen, Jonna Skov Madsen, Kjeld Schmiegelow, Rene Mathiasen, Tore Bjerregaard Stage +8 morewiley +1 more sourceIsolation, Identification, and Management Strategies for the Root Rot Pathogen of <i>Cardamine violifolia</i>. [PDF]
Biology (Basel)Gao S, Yang W, Bai W, Niu Y, Qiao Y, Dai Y, Si Y, Liu X, Xiang J, Pei Z, Liang A, Xiao Y, Cong X, Zeng J. +13 moreeuropepmc +1 more sourceSupratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care
British Journal of Clinical Pharmacology, EarlyView.Aims
Electronic triggers (e‐triggers) are used as screening signals to detect potential adverse drug events (ADEs) and offer an effective system level approach for medication safety surveillance. Their clinical utility is typically evaluated through time‐consuming manual chart review by experts, limiting implementation.Anne Paulien Langermans, Izak A. R. Yasrebi‐de Kom, Dylan Wayne de Lange, Nicolette Fransisca de Keizer, Joanna E. Klopotowska, on behalf of the RESCUE Study group, C. S. C. Bouman, E. N. van Roon, P. F. Schutte, J. ten Cate, D. van Balen, S. Hendriks, C. Lau, W. J. Vermeijden, A. Beishuizen, J. B. Masselink, P. E. Spronk, H. J. M. van Kan, P. W. de Feiter, E. J. Wils, A. Wieringa, A. J. Valkenburg, W. M. van den Bergh, M. H. Renes, W. Bult, E. de Jonge, M. Hoeksema, E. J. Wesselink, I. M. Purmer, B. E. Bosma, S. H. W. van Bree, H. J. W. Lammers, R. J. Bosman, E. J. F. Franssen, A. Karakus, M. Sigtermans, E. M. Kuck, D. A. Dongelmans, M. J. H. Aries, E. V. Uijtendaal, M. C. Reuland +40 morewiley +1 more sourceCharacteristics and temporal trends of EU teratological safety signals and information dissemination to healthcare professionals in the Netherlands—A contribution of the ConcePTION project
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim
Although regulatory responses to safety signals have been studied, pregnancy‐specific data and their dissemination to medical professionals remain unclear. This study examined the characteristics and temporal trends of teratological safety signals prompting the European Medicines Agency to implement risk minimization measures.Yrea R. J. van Rijt‐Weetink, Rosanne E. Huisman, Jan‐Peter van Wieringen, H. J. M. J. (Ineke) Crijns, Florence P. A. M. van Hunsel, Anneke L. M. Passier, Sander Borgsteede, A. C. G. (Toine) Egberts, Laura M. Yates, Eugène P. van Puijenbroek +9 morewiley +1 more sourceModeling the environment-related risk of frogeye leaf spot (Cercospora sojina) in soybean across the United States. [PDF]
Sci RepGonzález-Acuña JF, Allen TW, Bish MD, Bradley CA, Camiletti BX, Chilvers MI, Dangal NK, Diaz-Arias MM, Fakhoury AM, Faske TR, Gleason ML, Hansen BC, Kelly HM, Lopez-Nicora HD, Lux L, Malvick DK, Mangel D, Markell SG, Mueller DS, Price PP, Renfroe-Becton H, Scherer JM, Sikora EJ, Smith DL, Striegel A, Telenko DEP, Webster RW. +26 moreeuropepmc +1 more sourceEvaluation of a pantoprazole and 4‐desmethylpantoprazole‐sulfate metabolic ratio as a novel CYP2C19 phenotyping method
British Journal of Clinical Pharmacology, EarlyView.Aims
CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.Julian Peter Müller, Vladimir N. Belov, Sabrina Yamoune, Bob Miller, Mohammed Hasoumi, Jolanta Tupiec, Thea Laurentius, L. Cornelius Bollheimer, Julia C. Stingl, Katja S. Just +9 morewiley +1 more source